Click here to close Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly. We suggest using a current version of Chrome, FireFox, or Safari.
Return to search results

GEO Series: GSE77281

Title: RNA-seq based identification of potential RARgamma target genes in Xenopus laevis

Summary

The development of massively parallel sequencing technologies has revolutionized transcriptome analysis. Sequencing of total cDNA (RNA-Seq) can determine the expression levels of known and novel transcripts with high sensitivity from various developmental stages or conditions. Here we report a robust method for RNA-Seq in Xenopus laevis and apply it to understanding how modulation of retinoic acid signaling alters the transcriptome in early Xenopus laevis development. Three biological conditions were tested: early blastula stage embryos were treated with 1. a retinoic acid receptor (RAR) agonist NRX204647 (4647) at a concentration that stimulated all 3 RAR subtypes (alpha, beta, and gamma); 2. The same agonist at an RAR[gamma] selective dose, and 3. vehicle control. Five single-clutch replicates were obtained for each chemical treatment group, and harvested at neurula stage. We found that single-clutch replicates reflect the stochastic variation of the general outbred population and contribute more statistical power to RNA-Seq experiments due to their feasibility of replication. Our RNA-Seq dataset identified 1590 up-regulated and 685 down-regulated unique genes differentially regulated by all RAR subtypes, and 160 up-regulated and 60 down-regulated genes likely to be regulated specifically by RAR[gamma]. Differential expression detected by RNA-Seq was validated for selected genes by QPCR, which demonstrated nearly 100% quantitative agreement with the deep sequencing data. We further validated RAR-responsive genes by comparison with two previous, published microarray datasets and found substantial agreement. Gene ontology analysis identified RAR targets which may underlie such developmental processes as axial elongation, neurogenesis/synaptogenesis, dorsoventral regulation of the retina, homeotic fate specification, and central nervous system development. We investigated RAR[gamma]-selective targets identified by RNA-Seq and inferred that transcriptional repression by unliganded RARs is of substantial importance to embryonic patterning events. Overall, this paper demonstrates the utility of RNA-Seq in Xenopus laevis, obviating the perceived requirement to use X. tropicalis for genomic analyses.


Contributors: Toshi Shioda, Amanda Janesick, Weiyi Tang, Bruce Blumberg

Experiment Type: Xenopus laevis early blastula stage embyos were exposed to (1) 0.1% EtOH as vehicle, (2) an RARgamma-selective dose (10 nM) NRX204647, and (3) a high dose (1 microM) of NRX204647, which activates all three RAR subtypes (RARalpha, beta, gamma). Each exposure group cosisted of five single-clutch replicates.

Experiment Reagents: Ethanol, NRX-204647.

Phenotypes:
Xla Wt + NRX-204647 + WE NF18 - RNA-Seq (RNA)

Source: NCBI GEO, Xenbase Download

Samples: (DEG = Differentially Expressed Genes; GSM = GEO Sample Number)
Sample View GSMs Assay Type
WE + EtOH - NF18 GSM2047238  GSM2047239  GSM2047240  GSM2047241  GSM2047242  RNA-Seq
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
chemical Ethanol NF stage 6 (32-cell) embryo
Conditions:
Tissue Assay Stages ChIP Antibody
embryo NF stage 18  
   WE + NRX-204647 (High) - NF18 DEG GSM2047228  GSM2047229  GSM2047230  GSM2047231  GSM2047232  RNA-Seq
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
chemical NRX-204647 NF stage 6 (32-cell) embryo
Conditions:
Tissue Assay Stages ChIP Antibody
embryo NF stage 18  
   WE + NRX-204647 - NF18 DEG GSM2047233  GSM2047234  GSM2047235  GSM2047236  GSM2047237  RNA-Seq
Background: Xla.Outbred
Manipulations:
Manipulation Type Reagent Target Gene Stage Treatment Area
chemical NRX-204647 NF stage 6 (32-cell) embryo
Conditions:
Tissue Assay Stages ChIP Antibody
embryo NF stage 18  
Select All DEG      Select All 
Xtr   
Xla 

Return to search results